Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Pygopus 2 helps ovarian cancer cells grow by aiding ribosomal RNA production, independent of Wnt signaling.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Blocking mTORC1 reduces skin tumor growth in mice.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Tet1/2/3 enzymes affect hair follicle cell development by influencing BMP signaling.

Truncating mutations in the C2orf37 gene cause Woodhouse–Sakati syndrome.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

TMPRSS6 is crucial for controlling hepcidin and normal iron absorption.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Ets2 gene is crucial for placental development in mice.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.